自身抗体阴性的自身免疫性肝炎重叠原发性胆汁性胆管炎及原发性硬化性胆管炎1例报告

孟淼; 胡臻; 龚镭; 陆忠华; 彭晓斌; 唐学军; 王小云

doi:10.3969/j.issn.1001-5256.2019.08.032

自身抗体阴性的自身免疫性肝炎重叠原发性胆汁性胆管炎及原发性硬化性胆管炎1例报告

DOI: 10.3969/j.issn.1001-5256.2019.08.032

无锡市第二人民医院消化内科

基金项目:

江苏省青年重点人才项目(QNRC2016151)；江苏省自然面上项目(BK20151116)；

详细信息

中图分类号: R575
计量
- 文章访问数: 1582
- HTML全文浏览量: 15
- PDF下载量: 249
- 被引次数: 0
出版历程
- 出版日期: 2019-08-20

Autoantibody-negative autoimmune hepatitis overlapping with primary biliary cholangitis and primary sclerosing cholangitis: A case report

Department of Gastroenterology, The Second People's Hospital of Wuxi

Research funding:

摘要

摘要: <正>自身免疫性肝病是一组病因不明、免疫介导的肝损伤,包括自身免疫性肝炎（AIH）、原发性胆汁性胆管炎（PBC）、原发性硬化性胆管炎（PSC）[1],其患病率分别为25/10万～40/10万、17/10万及0. 9/10万～1. 3/10万[2-4]。临床上有小部分患者同时或在病程的不同阶段,具有其中两种或两种以上疾病的临床、生化、免疫及组织学特征时称为重叠综合征[5],报道较多的主要有AIH/PBC、AIH/PSC两种类型。AIH/PBC重叠综合征存在于8%～10%的AIH或PBC患者中[6-7],AIH/PSC重叠综
- 肝炎,自身免疫性 /
- 原发性胆汁性胆管炎 /
- 胆管炎,硬化性
- hepatitis, autoimmune /
- primary biliary cholangitis /
- cholangitis, sclerosing

HTML全文

参考文献(22)

[1] UMEMURA T, ZEN Y, HAMANO H, et al. IgG4 associated autoimmune hepatitis:A differential diagnosis for classical autoimmune hepatitis[J]. Gut, 2007, 56 (10) :1471-1472.

[2] KIM WR, LINDOR KD, LOCKE GR 3rd, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community[J]. Gastroenterology, 2000, 119 (6) :1631-1636.

[3] PRINCE MI, JAMES OF. The epidemiology of primary biliary cirrhosis[J]. Clin Liver Dis, 2003, 7 (4) :795-819.

[4] BOBERG KM. Prevalence and epidemiology of autoimmune hepatitis[J]. Clin Liver Dis, 2002, 6 (3) :635-647.

[5] YADA N, KUDO M, CHUNG H, et al. Autoimmune hepatitis and immunoglobulin G4-associated autoimmune hepatitis[J]. Dig Dis, 2013, 31 (5-6) :415-420.

[6] CHAZOUILLRES O, WENDUM D, SERFATY L, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome:Clinical features and response to therapy[J]. Hepatology, 1998, 28 (2) :296-301.

[7] HEURGUA, VITRY F, DIEBOLD MD, et al. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis:A retrospective study of 115 cases of autoimmune liver disease[J]. Gastroenterol Clin Biol, 2007, 31 (1) :17-25.

[8] WILSCHANSKI M, CHAIT P, WADE JA, et al. Primary sclerosing cholangitis in 32 children:Clinical, laboratory, and radiographic features, with survival analysis[J]. Hepatology, 1995, 22 (5) :1415-1422.

[9] MOHAMED E, MATRAWY KA. Primary sclerosing cholangitis:Evaluation with MR cholangiopancreatography (MRCP) [J].Egyptian J Radiol Nuclear Med, 2011, 42 (3-4) :351-356.

[10] BURAK KW, URBANSKI SJ, SWAIN MG. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis:A new overlap of autoimmune liver diseases[J]. Dig Dis Sci, 2001, 46 (9) :2043-2047.

[11] TERZIROLI BERETTA-PICCOLI B, MIELI-VERGANI G, VERGANI D. Autoimmune hepatitis:Standard treatment and systematic review of alternative treatments[J]. World J Gastroenterol, 2017, 23 (33) :6030-6048.

[12] European Association for the Study of the Liver. EASL clinical practice guidelines:Management of cholestatic liver diseases[J]. J Hepatol, 2009, 51 (2) :237-267.

[13] FLOREANI A, RIZZOTTO ER, FERRARA F, et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome[J]. Am J Gastroenterol, 2005, 100 (7) :1516-1522.

[14] Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and management of autoimmune hepatitis (2015) [J]. J Clin Hepatol, 2016, 32 (1) :9-22. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识[J].临床肝胆病杂志, 2016, 32 (1) :9-22.

[15] OMORI K, YOSHIDA K, YOKOTA M, et al. Familial occurrence of autoimmune liver disease with overlapping features of primary biliary cholangitis and autoimmune hepatitis in a mother and her daughter[J]. Clin J Gastroenrerology, 2016, 9 (5) :312-318.

[16] CHAZOUILLRES O. Overlap syndromes[J]. Dig Dis, 2015, 33 (Suppl 2) :181-187.

[17] LI Q, HUANG YX, CHEN L. Current status of the clinical diagnosis and treatment of overlap syndrome[J]. Chin Hepatol, 2016, 21 (3) :210-214. (in Chinese) 李强, 黄玉仙, 陈良.重叠综合征临床诊治现状[J].肝脏, 2016, 21 (3) :210-214.

[18] GREGORIO GV, PORTMANN B, KARANI J, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood:A 16-year prospective study[J]. Hepatology, 2001, 33 (3) :544-553.

[19] European Association for the Study of the Liver. EASL clinical practice guidelines:Autoimmune hepatitis[J]. J Hepatol, 2015, 63 (4) :971-1004.

[20] LI B, WANG QX, MA X. Research advances in autoimmune liver diseases in 2016[J]. Chin J Hepatol, 2017, 25 (2) :100-104. (in Chinese) 李博, 王绮夏, 马雄.自身免疫性肝病2016年研究进展[J].中华肝脏病杂志, 2017, 25 (2) :100-104.

[21] CZAJA AJ. Current and prospective pharmacotherapy for autoimmune hepatitis[J]. Expert Opin Pharmacother, 2014, 15 (12) :1715-1736.

[22] ZHANG J, WANG QX, MA X. Advances in immunological treatment of autoimmune hepatitis[J]. J Clin Hepatol, 2016, 32 (10) :1874-1877. (in Chinese) 张琚, 王绮夏, 马雄.自身免疫性肝炎免疫学治疗进展[J].临床肝胆病杂志, 2016, 32 (10) :1874-1877.

施引文献

资源附件(0)

访问统计